JNJ's Crucell halts supply of 2.36 mln flu vaccines to Italy
PARIS Oct 17 (Reuters) - Crucell, the vaccines unit of U.S. drugmaker Johnson & Johnson , has suspended a delivery of 2.36 million seasonal flu vaccine doses to Italy after it found problems with two lots of it, the Italian health ministry said on Wednesday.
The ministry said in a statement that the Netherlands-based vaccine maker halted the planned supply of its Inflexal V vaccine after two lots out of 32 failed quality checks.
Crucell was not immediately available for comment.
Italy's flu vaccination campaign will start as planned because health authorities will fill in the shortfall by purchasing more doses from other manufacturers, the statement said.
Italy uses between 10 and 12 million doses of flu vaccines every year, the health ministry said.
- North Korea says Kim's powerful uncle dismissed for 'criminal acts'
- Thai PM calls snap election, protesters press on |
- Protesters fell Lenin statue, tell Ukraine's president 'you're next'
- Singapore hit by rare outbreak of rioting, 27 arrested |
- Venezuela's Maduro to raise pressure on business after local vote